Skip to main content
Terug
Watch Compare

BIO-PATH HOLDINGS, INC.

Datakwaliteit: 83%
BPTH
OTC Manufacturing Chemicals
€ 0,06
€ 0,00 (0,00%)
Marktkapitalisatie: 467.107,0
Prijs
€ 0,05
Marktkapitalisatie
467.107,0
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -4,48 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio0,08
Interest CoverageN/A

Waardering

PE (TTM)
-0,04
Boven sectorgemiddelde (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E 0,0 -1,5
P/B — 1,6
ROE % — -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,9
D/E — 0,3

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q22025 -€ 0,40 -€ 0,55 -37,5%
Q12025 -€ 0,38 -€ 0,40 -5,3%
Q42024 -€ 0,37 -€ 0,07 +81,1%
Q32024 -€ 1,02 -€ 0,70 +31,4%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -11,18 M
ROE N/A ROA -1556,82%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -4,48 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,08
Interest Coverage N/A Asset Turnover N/A
Working Capital -8,02 M Tangible Book Value -8,00 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,04 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -958,45%
Market Cap 467.107,0 Enterprise Value 467.107,0
Per Share
EPS (Diluted TTM) -1,14 Revenue / Share N/A
FCF / Share -0,48 OCF / Share -0,48
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 40,05%
SBC-Adj. FCF -4,77 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -9,89 M -16,08 M -13,87 M -10,44 M -10,88 M
EPS (Diluted) -4,12 -33,63 -1,91 -1,55 —
Gross Profit — — — — —
Operating Income -11,99 M -15,84 M -13,90 M -10,44 M -10,91 M
EBITDA — — — — —
R&D Expenses 7,30 M 11,61 M 9,17 M 5,91 M 6,58 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 3,88 M 3,22 M 15,97 M 26,57 M 16,48 M
Total Liabilities 3,73 M 2,78 M 1,80 M 1,11 M 1,41 M
Shareholders' Equity 154.000,0 441.000,0 14,17 M 25,46 M 15,07 M
Total Debt — — — — —
Cash & Equivalents — — — — —
Current Assets 3,78 M 3,04 M 15,62 M 26,14 M 15,96 M
Current Liabilities 3,30 M 1,91 M 1,68 M 958.000,0 1,17 M